Acute bronchitis primary prevention

Chronic Obstructive Pulmonary Disease Page
Bronchitis Main Page
Acute bronchitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Acute bronchitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Acute bronchitis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute bronchitis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute bronchitis primary prevention
CDC on Acute bronchitis primary prevention
Acute bronchitis primary prevention in the news
Blogs on Acute bronchitis primary prevention
Directions to Hospitals Treating Acute bronchitis
Risk calculators and risk factors for Acute bronchitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Onset can be mitigated through various prevention methodologies. Vaccinations serve to as an effective mechanism for primary prevention.

Prevention

In 1985, University of Newcastle, Australia Professor Robert Clancy developed an oral vaccine for acute bronchitis. This vaccine was commercialized four years later as Broncostat.

References

Template:WikiDoc Sources